aod9604 weight loss evidence clinical trials AOD 9604 Peptide for Management AOD-9604: The Future of Weight

What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry

Check the labels to make sure B12 is included

Injections are quick and convenient and can often be added to your regular visit

However, common symptoms of vitamin B12 deficiency include fatigue, weakness, pale skin, shortness of breath, and tingling or numbness in the hands and feet

you need to get it from food or oral supplements